Association of PM <sub>2.5</sub> Exposure and Alzheimer Disease Pathology in Brain Bank Donors—Effect Modification by <i>APOE</i> Genotype
Grace M. Christensen, Zhenjiang Li, Donghai Liang, Stefanie Ebelt, Marla Gearing, Allan I. Levey, James J. Lah, Aliza P. Wingo, Thomas S. Wingo, Anke Hüls
Abstract
Fine particulate matter (PM2.5) exposure has been found to be associated with Alzheimer disease (AD) and is hypothesized to cause inflammation and oxidative stress in the brain, contributing to neuropathology. The APOE gene, a major genetic risk factor of AD, has been hypothesized to modify the association between PM2.5 and AD. However, little prior research exists to support these hypotheses. This study investigates the association between traffic-related PM2.5 and AD hallmark pathology, including effect modification by APOE genotype, in an autopsy cohort.
Topics & Concepts
Apolipoprotein ENeuropathologyMedicineOdds ratioAlzheimer's diseaseInternal medicineCohortDiseasePathologyOncologyAir Quality and Health ImpactsClimate Change and Health ImpactsEnergy and Environment Impacts